MOONLAKE IMMUNOTHERAPEUTICS Capital Expenditures
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for fiscal 2025 was $35.00K, a 93.27% decline from fiscal 2024.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for fiscal 2024 was $520.00K, a 83.10% increase from fiscal 2023.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for fiscal 2023 was $284.00K, a 1674.00% increase from fiscal 2022.
- MOONLAKE IMMUNOTHERAPEUTICS payments to acquire property, plant, and equipment for fiscal 2022 was $16.01K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 10 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $35.00K 10-K · filed 2026-02-25 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $35.00K 10-Q · filed 2025-11-05 | $211.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $35.00K 10-Q · filed 2026-08-10 | $211.00K derived: sum of 3 quarters · filed 2026-08-10 | $343.00K derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | $35.00K 10-Q · filed 2026-05-11 | $211.00K derived: sum of 2 quarters · filed 2026-05-11 | $343.00K derived: sum of 3 quarters · filed 2026-05-11 | $343.00K derived: sum of 4 quarters · filed 2026-05-11 | |||||
| 2024-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $308.00K derived: sum of 2 quarters · filed 2026-02-25 | $308.00K derived: sum of 3 quarters · filed 2026-02-25 | $520.00K 10-K · filed 2026-02-25 | $519.52K 10-K · filed 2025-02-26 | ||||
| 2024-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $132.00K derived: sum of 2 quarters · filed 2025-11-05 | $344.00K 10-Q · filed 2025-11-05 | $343.95K 10-Q · filed 2024-11-07 | $628.00K derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $212.00K 10-Q · filed 2025-08-05 | $211.76K 10-Q · filed 2024-08-07 | $496.00K derived: sum of 3 quarters · filed 2026-02-25 | $496.00K derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $212.00K 10-Q · filed 2025-05-12 | $211.76K 10-Q · filed 2024-05-07 | $496.00K derived: sum of 2 quarters · filed 2026-02-25 | $496.00K derived: sum of 3 quarters · filed 2026-02-25 | $496.00K derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $284.00K derived: sum of 2 quarters · filed 2026-02-25 | $284.00K derived: sum of 3 quarters · filed 2026-02-25 | $284.00K 10-K · filed 2026-02-25 | $284.63K 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $1.00 derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $1.00 derived: sum of 3 quarters · filed 2025-02-26 | $1.00 derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $1.00 derived: sum of 2 quarters · filed 2025-02-26 | $1.00 derived: sum of 3 quarters · filed 2025-02-26 | -$1.00 derived: sum of 4 quarters · filed 2025-02-26 | |||||
| 2022-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.00 derived: sum of 2 quarters · filed 2025-02-26 | -$1.00 derived: sum of 3 quarters · filed 2025-02-26 | $16.01K 10-K · filed 2025-02-26 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.00 derived: sum of 2 quarters · filed 2023-11-14 | $16.01K 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$2.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $16.01K 10-Q · filed 2023-08-10 | |||||||
| 2022-03-31 | $16.01K 10-Q · filed 2023-05-11 | ||||||||
| 2021-12-31 | $50.71K 10-K · filed 2023-03-20 | ||||||||
| 2021-09-30 | $11.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $32.33K 10-Q · filed 2022-11-14 | |||||||
| 2021-06-30 | $20.68K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |